Home › SEC Filings › Insider Cluster Activity
Insider Cluster Activity
All Current Report (8-K)Annual Report (10-K)Quarterly Report (10-Q)Form 4 Insider TradesSC 13D Beneficial Ownership13F Institutional HoldingsPress ReleasesInsider Cluster ActivityInsider Buy Activity
Theme?
All themes Artificial IntelligenceSemiconductorsQuantum ComputingSpace & SatellitesRobotics & AutomationElectric VehiclesClean & Renewable EnergyBattery & Energy StorageNuclear & FusionCybersecurityCloud & SaaSFintech & PaymentsCrypto & BlockchainGenomics & Gene EditingBiotech & Drug DiscoveryE-commerce & PlatformsStreaming & Digital MediaGaming & EsportsDefense TechCannabis
| Ticker | Type | Sentiment | Impact | Summary | Date |
|---|---|---|---|---|---|
| ADPT | CLUSTER | bearish | 5/10 | Two ADPT insiders sold a combined $3.05M in open-market sales over a 7-day window. The vast majority ($3.01M) came from | Sep 18, 2026 |
| SKYE | CLUSTER | bearish | 4/10 | Two 10% owners of Skye Bioscience sold a combined $125K in open-market sales at $1.91/share within a 7-day window. The t | Sep 18, 2026 |
| RVMD | CLUSTER | bearish | 5/10 | Three insiders at Revolution Medicines sold a total of $5.37M in stock over a one-week window, led by a $4.33M sale by a | Sep 18, 2026 |
| UTHR | CLUSTER | neutral | 4/10 | CEO Martine Rothblatt sold ~$7.5M in open-market shares over three days (Sep 14-16), following a $477.6M accelerated sha | Sep 18, 2026 |
| ARQT | CLUSTER | neutral | 2/10 | Two insiders at Arcutis Biotherapeutics sold a combined $206K in open-market sales over a one-week window. Director Howa | Sep 18, 2026 |
| ICLR | CLUSTER | bearish | 4/10 | Two ICON PLC directors sold a combined $1.45M in open-market transactions on September 17, 2026, at ~$175/share. The sal | Sep 18, 2026 |
| TENX | CLUSTER | bullish | 5/10 | Three insiders at Tenax Therapeutics, including the CEO and CFO, made open-market purchases totaling $122K over a one-we | Sep 17, 2026 |
| TVTX | CLUSTER | bearish | 4/10 | Two Travere insiders sold a combined $377K in open-market sales over a one-week window. Director Jeffrey Meckler sold $1 | Sep 17, 2026 |
| PVLA | CLUSTER | bearish | 6/10 | Director George M. Jenkins sold a total of ~27,500 shares worth ~$4.17M in open-market sales over three trading days (Se | Sep 17, 2026 |
| CBIO | CLUSTER | neutral | 3/10 | CEO Joshua Brumm and President/COO Jonathan McNeill sold a combined $195K of CBIO stock on September 18, 2026, at $16.71 | Sep 17, 2026 |
| ROIV | CLUSTER | neutral | 2/10 | Two Roivant directors sold a combined ~$359K in open-market transactions on September 15, 2026, at ~$39.65-$40.45 per sh | Sep 17, 2026 |
| ROIV | CLUSTER | neutral | 2/10 | Two Roivant directors sold a combined ~$359K in open-market sales on September 15, 2026. The total value is ~0.1% of mar | Sep 17, 2026 |
| ROIV | CLUSTER | neutral | 2/10 | Two Roivant Sciences directors sold a combined ~$359K in open-market transactions on September 15, 2026. The sales are m | Sep 17, 2026 |
| INBX | CLUSTER | bullish | 5/10 | Inhibrx Biosciences (INBX) insider cluster shows a director (Kayyem) making a $500K open-market purchase at $100/share, | Sep 17, 2026 |
| HALO | CLUSTER | neutral | 2/10 | CEO Helen Torley exercised 20,000 options at $18.41 and immediately sold 20,000 shares on the open market at ~$107.15, n | Sep 17, 2026 |
| PHVS | CLUSTER | bearish | 5/10 | Six Pharvaris insiders, including the CEO, President, and CCO, sold a total of ~$4.13M in open-market shares over a one- | Sep 17, 2026 |
| PHVS | CLUSTER | bearish | 5/10 | A cluster of insider sales at Pharvaris N.V. over the past week totaled approximately $2.41M in open-market sales, led b | Sep 17, 2026 |
| PBYI | CLUSTER | bearish | 4/10 | Two directors at Puma Biotechnology sold a combined $612K in open-market shares over a one-week window, with the bulk ($ | Sep 16, 2026 |
| UTHR | CLUSTER | neutral | 3/10 | CEO Martine Rothblatt sold ~$6.7M of UTHR stock over Sept 11-14, 2026, alongside director Nilda Mesa's small sale. The s | Sep 16, 2026 |
| ARQT | CLUSTER | neutral | 2/10 | Two insiders at Arcutis Biotherapeutics sold a combined $364K in open-market sales over a week. The sales are modest rel | Sep 16, 2026 |
| TYRA | CLUSTER | bullish | 8/10 | Two Tyra Biosciences insiders, including 10% owner RA Capital Management, made open-market purchases totaling $200.01M f | Sep 16, 2026 |
| MRNA | CLUSTER | bearish | 5/10 | Moderna CFO James Mock sold $4.68M in open-market shares on September 10, 2026, following option exercises, while Presid | Sep 16, 2026 |
| PHVS | CLUSTER | bearish | 6/10 | Five Pharvaris insiders, including the CEO, President, and Chief Commercial Officer, collectively sold $2.93M in open-ma | Sep 16, 2026 |
| AQST | CLUSTER | neutral | 3/10 | Insider cluster at Aquestive (AQST) is dominated by a single open-market SELL from CCO Sherry Korczynski ($46K) plus a s | Sep 16, 2026 |
| RVMD | CLUSTER | neutral | 2/10 | Two insiders at Revolution Medicines sold shares in a cluster totaling ~$1.37M in open-market sales, with additional der | Sep 16, 2026 |
| INBX | CLUSTER | neutral | 4/10 | Inhibrx Biosciences (INBX) insiders showed mixed activity in early September 2026: three directors/executives made open- | Sep 16, 2026 |
| UTHR | CLUSTER | neutral | 2/10 | CEO Martine Rothblatt sold ~$1.37M in open-market shares on Sept 14, 2026, part of a larger cluster of option exercises | Sep 16, 2026 |
| CYTK | CLUSTER | bearish | 5/10 | Cytokinetics CEO Robert Blum sold $7.3M in open-market shares (97,926 shares at $69.33 and 7,500 at $73.44) alongside di | Sep 16, 2026 |
| NTHI | CLUSTER | neutral | 5/10 | No summary provided | Sep 15, 2026 |
| CSTL | CLUSTER | neutral | 2/10 | Two Castle Biosciences insiders, including the CEO and CCO, sold a combined $110K in shares over a week. The CEO's sale | Sep 15, 2026 |